
U.S. stock indexes are mixed, with the S&P 500 and Dow slightly higher while the Nasdaq lags, as stronger-than-expected August personal spending and in-line core PCE inflation data supported Fed rate cut expectations, though consumer sentiment unexpectedly fell. Key sector movements include semiconductor stocks rising on reports of a Trump administration plan to boost domestic manufacturing, and pharmaceutical stocks gaining despite proposed import tariffs, viewed as beneficial due to existing U.S. production. This occurs amidst rising Q3 corporate earnings expectations and concerns over a potential government shutdown.
The US equity market is exhibiting a mixed performance, with the S&P 500 and Dow Jones Industrials posting modest gains while the Nasdaq 100 declines, reflecting a complex interplay of economic signals and policy-driven sector rotation. The broader market is supported by robust macroeconomic data, including a stronger-than-expected 0.6% month-over-month increase in August personal spending and an in-line August core PCE price index reading of +2.9% year-over-year. This inflation data, coupled with a downward revision in the University of Michigan's inflation expectations, underpins the market's pricing of an 86% probability of a 25 bp Fed rate cut in October. However, sentiment is being tempered by an unexpected drop in the University of Michigan's consumer sentiment index to a four-month low and the looming risk of a US government shutdown. Sector-level performance is highly divergent; news of a potential plan to boost domestic chip manufacturing has lifted stocks like GlobalFoundries (+5%) and Intel (+3%), while other semiconductor firms like AMD and Marvell are down over 2%. Similarly, proposed tariffs are paradoxically boosting pharmaceutical and industrial names with strong US manufacturing footprints, such as Paccar (+5%). This is all set against a bullish backdrop of rising corporate earnings expectations, with S&P 500 Q3 growth forecast at +6.9%.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment